DXCM DexCom, Inc. - Common Stock

NASDAQ · Health Care · Ver en SEC EDGAR ↗
$90,75
Precio · Ago 18, 2026
Fundamentales a fecha de Jul 30, 2026

Acerca de DexCom, Inc. - Common Stock Descripción general de la empresa de Wikipedia

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.

Leer más

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.

History

Dexcom was founded in 1999 by Scott Glenn, John Burd, Lauren Otsuki, Ellen Preston and Bret Megargel. In 2006, Dexcom received U.S. Food and Drug Administration (FDA) approval and launched the Dexcom STS Continuous Glucose Monitoring System, which is a three-day sensor that provides up to 288 glucose measurements for every 24 hours. Dexcom received approval of the second-generation product, the Seven Continuous Glucose Monitoring System, in May 2007. This device improved on accuracy and extended use from three to seven days. In 2008, Dexcom announced two consumer development agreements with Insulet Corporation and Animas Corporation as well as a development agreement with Edwards Lifesciences for a continuous glucose monitor in the intensive care unit hospital environment.

During February 2009, Dexcom received approval for the Seven Plus Continuous Glucose Monitor, its new continuous glucose monitoring system, from the FDA. This product received a CE mark in November 2009. In 2013, development work for integration with Insulet was discontinued. Dexcom entered a non-exclusive agreement with Tandem Diabetes Care, Inc. in 2015 to allow the integration of its forthcoming G5 and G6 continuous glucose monitoring systems into Tandem's insulin pumps. The G5 was approved in 2016 by the FDA for use as a standalone device, while the G6 gained approval in 2018.

Dexcom's first G-series CGM, the G4 Platinum, received a CE mark and FDA approval in 2012 for adults ages 18 and over. This device improved hypoglycemic accuracy by 30%. It also offered a longer range of transmission between the sensor and receiver, as well as a color LCD. The G4 Platinum was approved by the FDA for use in patients ages 2–17 in February 2014. Dexcom received FDA approval in January 2015 for the G4 Platinum with Share, which enabled the sharing of CGM data with up to five other people using the "Share" and "Follow" smartphone apps.

The Dexcom G5 was approved in August 2015 by the FDA for use as a standalone device, the G5 has Bluetooth integrated into its transmitter, enabling it to send data to a mobile device. This allows for use of the device without the standalone receiver. The Dexcom G5 received a CE mark in September 2015.

Dexcom went public in 2005 and is listed on the Nasdaq Global Select Market stock exchange under the ticker symbol DXCM. On April 20, 2020, Dexcom became a component of the Nasdaq-100, replacing American Airlines Group in the index.

The Dexcom G7 was approved in December 2022 by the FDA for use as a standalone device. The Dexcom G7 15-Day is the most accurate currently approved CGM in the U.S.

Awards and recognition

In October 2024, Time Magazine named Dexcom Stelo's over-the-counter glucose monitor one of the year's best inventions.

Partnerships

Dexcom entered into a partnership in 2015 with Google Life Sciences (which subsequently became Verily) to develop the Dexcom G7

Dexcom entered a non-exclusive agreement with Tandem Diabetes Care, Inc. in 2015 to allow the integration of its new G5 and G6 continuous glucose monitoring systems into Tandem's insulin pumps. Tandem Diabetes Care received FDA approval in December 2019 for Control-IQ, a closed-loop technology that uses Tandem's t:slim X2 insulin pump and the Dexcom G6 "to automatically increase, decrease, or stop the delivery of insulin in response to the glucose levels of people with Type 1 diabetes."

In June 2019, Dexcom announced a collaboration with Companion Medical to enable the exchange of CGM data from Dexcom with insulin data from InPen into both companies' software applications.

Dexcom entered into a partnership with Livongo, a digital chronic care management company, in January 2020 to share CGM data from the Dexcom G6 with Livongo's platform. This integration allowed Livongo to incorporate the CGM data along with other patient data.

In February 2020, Dexcom and Insulet Corporation signed a non-exclusive, global agreement to combine current and future Dexcom continuous glucose monitoring systems with Insulet's tubeless insulin delivery Pod into the Omnipod Horizon System for automated insulin delivery. This allowed the ability to adjust insulin doses based on Insulet's algorithm or through their smartphone.

The company also announced in March 2020 a partnership with Welldoc to integrate G6 CGM data with BlueStar, a digital platform for diabetes management.

In November 2024, Dexcom announced a "strategic partnership" and data exchange with Oura.

Venture capital arm

In early 2021, Dexcom launched Dexcom Ventures, a venture capital arm focused on emerging continuous glucose monitoring technologies and devices measuring the levels of other types of substances and analytes. In practice, Dexcom Ventures has also invested in cybersecurity platforms for the software used in medical devices.

Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗

Wikidata ↗

DXCM Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas

Precio
$90.75
Capitalización Bursátil
$35.02B
P/E (TTM)
43.5
BPA (TTM)
$2.09
Ingresos (TTM)
$4.66B
Rendimiento div.
ROE
31.4%
Deuda/Capital
Rango 52S
$54 – $92

DXCM Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista

Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA

Ingresos y Beneficio Neto $4.66B
10-point trend, +713.2%
2016-12-31 2025-12-31
BPA $2.09
9-point trend, +460.3%
2017-12-31 2025-12-31
Flujo de caja libre $1.08B
10-point trend, +215340.0%
2016-12-31 2025-12-31
Márgenes 17.9%
8-point trend, -6.6%
2018-12-31 2025-12-31

Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?

Métrica
Tendencia a 5 años
DXCM
Mediana de Pares
P/E (TTM)
5-point trend, -87.5%
43.5
26.3
P/S (TTM) (P/V (TTM))
5-point trend, +3.0%
7.5
4.4
P/B (P/C)
5-point trend, +60.8%
12.8
5.3
Price / FCF (Precio / FCF)
5-point trend, -90.3%
32.5

Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC

Métrica
Tendencia a 5 años
DXCM
Mediana de Pares
Gross Margin (Margen Bruto)
5-point trend, -12.4%
60.1%
63.1%
Operating Margin (Margen Operativo)
5-point trend, +80.1%
19.6%
Net Profit Margin (Margen de Beneficio Neto)
5-point trend, +183.9%
17.9%
15.6%
ROA
5-point trend, +285.8%
13.0%
7.6%
ROE
5-point trend, +323.3%
31.4%
15.0%
ROIC
5-point trend, +143.0%
25.5%

Salud financiera Deuda, liquidez, solvencia — solidez del balance general

Métrica
Tendencia a 5 años
DXCM
Mediana de Pares
Current Ratio (Ratio corriente)
5-point trend, -63.2%
1.9
1.7
Quick Ratio (Ratio Rápido)
5-point trend, -54.2%
1.0

Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años

Métrica
Tendencia a 5 años
DXCM
Mediana de Pares
Revenue YoY (Ingresos interanuales)
5-point trend, +90.4%
15.6%
Revenue CAGR 3Y (Ingresos CAGR 3A)
5-point trend, +90.4%
17.0%
Revenue CAGR 5Y (Ingresos CAGR 5A)
5-point trend, +90.4%
19.3%
EPS YoY (EPS interanual)
5-point trend, +294.3%
47.2%
Net Income YoY (Beneficio Neto interanual)
5-point trend, +285.6%
45.1%

Métricas por acción BPA, valor contable por acción, flujo de caja por acción, dividendo por acción

Métrica
Tendencia a 5 años
DXCM
Mediana de Pares
EPS (Diluted) (BPA (Diluido))
5-point trend, +294.3%
$2.09

Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar

Métrica
Tendencia a 5 años
DXCM
Mediana de Pares

DXCM Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista

COMPRA 36 analistas
  • Compra fuerte 15 41,7%
  • Compra 16 44,4%
  • Mantener 5 13,9%
  • Venta 0 0,0%
  • Venta fuerte 0 0,0%

Precio objetivo a 12 meses

25 analistas · 2026-08-14
Objetivo mediano $93.00 +2,5%
Objetivo medio $93.44 +3,0%

Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados

Sorpresa Media
0.05%
Período EPS Actual EPS est. Sorpresa
30 de junio de 2026 $0.70 $0.62 0.08%
31 de marzo de 2026 $0.56 $0.48 0.08%
31 de diciembre de 2025 $0.56 $0.48 0.08%
30 de septiembre de 2025 $0.61 $0.58 0.03%
30 de junio de 2025 $0.48 $0.45 0.03%
31 de marzo de 2025 $0.32 $0.33 -0.01%

Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector

Ticker Capitalización Bursátil P/E Ingresos interanuales Margen Neto ROE Margen Bruto
DXCM $25.54B 31.8 15.6% 17.9% 31.4% 60.1%
SYK $134.44B 41.8 11.2% 12.9% 15.1% 64.0%
BSX 49.1 19.9% 14.4% 12.6% 69.0%
EW $49.50B 46.6 11.6% 17.7% 10.6% 78.0%
BDX 25.3 8.2% 7.7% 6.5%
IDXX $53.93B 51.7 10.4% 24.6% 69.2% 61.8%
GEHC 18.0 4.8% 10.1% 22.1% 40.0%
RMD $28.11B 18.7 9.8% 26.9% 23.6% 61.1%
ZBH $28.66B 25.3 7.2% 8.6% 5.6%
BAX $13.05B -10.2 5.7% -8.5% -14.6% 30.0%
PEN $12.20B 68.8 17.5% 12.7% 13.1% 67.1%

Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja

Estado de resultados 18
Datos anuales de Estado de resultados para DXCM
Métrica Tendencia 202520242023202220212020201920182017201620152014
Revenue 10-point trend, +713.2% $4.66B $4.03B $3.62B $2.91B $2.45B $1.93B $1.48B $1.03B $718M $573M · ·
Cost of Revenue 12-point trend, +2143.8% $1.86B $1.59B $1.33B $1.03B $768M $647M $544M $368M $226M $195M $124M $83M
Gross Profit 12-point trend, +1489.3% $2.80B $2.44B $2.29B $1.88B $1.68B $1.28B $932M $664M $492M $378M $278M $176M
R&D Expense 12-point trend, +763.3% $599M $552M $506M $484M $517M $360M $274M $200M $185M $156M $138M $69M
SG&A Expense 12-point trend, +905.5% $1.29B $1.29B $1.19B $1.01B $810M $618M $516M $433M $349M $286M $198M $128M
Operating Expenses 12-point trend, +855.6% $1.89B $1.84B $1.69B $1.49B $1.41B $981M $789M $850M $535M $442M $336M $198M
Operating Income 12-point trend, +4340.9% $912M $600M $598M $391M $266M $300M $142M $-186M $-42M $-64M $-57M $-22M
Interest Expense 10-point trend, +2437.5% · · $20M $19M $19M $18M $60M $23M $13M $700.0K $400.0K $800.0K
Interest Income 4-point trend, +3300000.00 · · · · · · · · $3M $400.0K $0 $0
Other Non-op 12-point trend, +176600000.00 $177M $109M $113M $-400.0K $-9M $16M $26M $2M $7M $-700.0K $0 $0
Pretax Income 12-point trend, +4980.7% $1.09B $709M $710M $391M $257M $298M $104M $-126M $-49M $-65M $-58M $-22M
Income Tax 12-point trend, +252000.0% $252M $133M $169M $50M $40M $-252M $3M $600.0K $2M $700.0K $100.0K $100.0K
Net Income 12-point trend, +3833.5% $836M $576M $542M $341M $217M $550M $101M $-127M $-50M $-66M $-58M $-22M
EPS (Basic) 9-point trend, +469.0% $2.14 $1.46 $1.40 $0.88 $0.56 $1.46 $1.11 $-1.44 $-0.58 · · ·
EPS (Diluted) 9-point trend, +460.3% $2.09 $1.42 $1.30 $0.82 $0.53 $1.33 $1.10 $-1.44 $-0.58 · · ·
Shares (Basic) 9-point trend, +352.1% 390,200,000 393,600,000 386,000,000 389,400,000 386,900,000 377,500,000 91,100,000 88,200,000 86,300,000 · · ·
Shares (Diluted) 9-point trend, +369.9% 405,500,000 412,700,000 425,500,000 427,500,000 428,800,000 420,400,000 92,300,000 88,200,000 86,300,000 · · ·
EBITDA 12-point trend, +8982.4% $1.16B $818M $784M $547M $368M $367M $191M $-157M $-26M $-49M $-46M $-13M
Balance general 26
Datos anuales de Balance general para DXCM
Métrica Tendencia 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +1178.1% $918M $606M $566M $642M $1.05B $818M $446M $1.14B $442M $94M $86M $72M
Short-term Investments 2-point trend, +297.9% · · · · · · · · $93M $23M · ·
Receivables 12-point trend, +2768.2% $1.22B $1.01B $974M $713M $514M $428M $286M $227M $134M $102M $74M $42M
Inventory 12-point trend, +3831.9% $629M $543M $560M $307M $357M $235M $120M $71M $45M $45M $35M $16M
Prepaid Expense 12-point trend, +4756.4% $189M $174M $168M $193M $82M $54M $30M $16M $17M $9M $7M $4M
Other Current Assets 5-point trend, +6.6% $29M $29M $49M $27M $27M · · · · · · ·
Current Assets 12-point trend, +2664.4% $4.03B $4.30B $4.43B $3.67B $3.68B $3.42B $1.97B $1.70B $745M $280M $231M $146M
PP&E (Net) 9-point trend, +3283.3% · · · $1.06B $802M $515M $321M $183M $146M $109M $55M $31M
PP&E (Gross) 9-point trend, +2116.9% · · · $1.42B $1.03B $670M $426M $263M $200M $157M $93M $64M
Accum. Depreciation 9-point trend, +1007.3% · · · $363M $232M $154M $105M $80M $55M $47M $38M $33M
Goodwill 12-point trend, +656.2% $24M $23M $25M $26M $26M $19M $19M $19M $12M $11M $4M $3M
Intangibles 8-point trend, +2522.2% $71M $103M $134M $173M $32M · · · · $200.0K $2M $3M
Other Non-current Assets 12-point trend, +46350.0% $279M $173M $75M $47M $10M $21M $14M $15M $2M $2M $100.0K $600.0K
Total Assets 12-point trend, +3334.4% $6.34B $6.48B $6.26B $5.39B $4.93B $4.29B $2.40B $1.92B $904M $403M $292M $185M
Current Liabilities 12-point trend, +5177.1% $2.14B $2.93B $1.56B $1.84B $721M $614M $360M $222M $139M $102M $67M $41M
Capital Leases 8-point trend, +73400000.00 $73M $65M $80M $95M $99M $102M $72M $0 · · · ·
Deferred Tax 3-point trend, +4900000.00 · · · $5M $6M $0 · · · · · ·
Other Non-current Liabilities 12-point trend, +9040.0% $137M $148M $126M $128M $90M $81M $20M $20M $18M $17M $4M $2M
Total Liabilities 12-point trend, +7994.4% $3.59B $4.38B $4.20B $3.26B $2.89B $2.46B $1.51B $1.25B $485M $119M $71M $44M
Long-term Debt · · · · · · · · · · · $5M
Retained Earnings 12-point trend, +588.9% $2.43B $1.60B $1.02B $480M $139M $-78M $-696M $-799M $-672M $-621M $-555M $-498M
Treasury Stock 9-point trend, +2084800000.00 $2.08B $1.58B $2.45B $595M $206M $100M $100M $100M $0 · · ·
AOCI 12-point trend, +115100.0% $115M $-8M $-17M $-12M $500.0K $3M $2M $2M $-3M $-1M $-300.0K $-100.0K
Stockholders' Equity 12-point trend, +1858.6% $2.75B $2.10B $2.07B $2.13B $2.04B $1.55B $883M $663M $419M $284M $221M $140M
Liabilities + Equity 12-point trend, +3334.4% $6.34B $6.48B $6.26B $5.39B $4.93B $4.29B $2.40B $1.92B $904M $403M $292M $185M
Shares Outstanding 12-point trend, +397.8% 384,800,000 390,700,000 385,400,000 386,300,000 388,000,000 384,400,000 366,400,000 90,000,000 87,000,000 84,600,000 81,700,000 77,300,000
Flujo de Efectivo 19
Datos anuales de Flujo de Efectivo para DXCM
Métrica Tendencia 202520242023202220212020201920182017201620152014
D&A 12-point trend, +2897.6% $252M $218M $186M $156M $102M $67M $49M $29M $16M $15M $11M $8M
Stock-based Comp 12-point trend, +219.2% $160M $170M $151M $126M $113M $119M $103M $102M $106M $111M $83M $50M
Deferred Tax 12-point trend, +182200000.00 $182M $-44M $-55M $-22M $16M $-260M $200.0K $-2M $0 $-200.0K $0 $0
Amort. of Intangibles 9-point trend, +600.0% $4M $7M $8M $8M $4M $2M · · · $700.0K $500.0K $600.0K
Restructuring · · · · · · $8M · · · · ·
Other Non-cash 12-point trend, +187.1% $11M $69M $-75M $68M $77M $73M $62M $122M $20M $-4M $13M $-12M
Operating Cash Flow 12-point trend, +6004.7% $1.44B $990M $748M $670M $442M $476M $314M $123M $92M $56M $49M $24M
CapEx 12-point trend, +2143.8% $364M $359M $237M $365M $389M $199M $180M $67M $66M $56M $33M $16M
Investing Cash Flow 12-point trend, +3290.5% $536M $-208M $-507M $-522M $-216M $-1.02B $-1.02B $-140M $-144M $-56M $-52M $-17M
Debt Issued · · · · · · · · · · · $0
Net Debt Issued 4-point trend, +100.0% · · · · · · · · $0 $-2M $-2M $-2M
Stock Issued 12-point trend, +17.1% $28M $28M $27M $22M $20M $15M $12M $11M $10M $10M $19M $24M
Stock Repurchased 10-point trend, +500000000.00 $500M $750M $689M $558M $0 $0 $0 $100M $0 $0 · ·
Net Stock Activity 12-point trend, -2066.2% $-472M $-722M $-662M $-535M $20M $15M $12M $-89M $10M $10M $19M $24M
Financing Cash Flow 12-point trend, -7835.8% $-1.69B $-735M $-319M $-552M $10M $912M $11M $710M $399M $8M $17M $22M
Net Change in Cash 12-point trend, +990.2% $312M $40M $-76M $-410M $235M $372M $-691M $696M $347M $8M $14M $29M
Taxes Paid $94M · · · · · · · · · · ·
Free Cash Flow 12-point trend, +14456.8% $1.08B $631M $512M $305M $53M $277M $134M $56M $26M $500.0K $16M $7M
Levered FCF 10-point trend, +7425.7% · · $496M $288M $-36M $91M $76M $33M $13M $-207.6K $15M $7M
Rentabilidad 8
Datos anuales de Rentabilidad para DXCM
Métrica Tendencia 202520242023202220212020201920182017201620152014
Gross Margin 8-point trend, -6.6% 60.1% 60.5% 63.2% 64.7% 68.6% 66.4% 63.1% 64.4% · · · ·
Operating Margin 8-point trend, +208.3% 19.6% 14.9% 16.5% 13.4% 10.9% 15.5% 9.6% -18.1% · · · ·
Net Margin 8-point trend, +245.6% 17.9% 14.3% 14.9% 11.7% 6.3% 25.6% 6.9% -12.3% · · · ·
Pretax Margin 8-point trend, +290.5% 23.4% 17.6% 19.6% 13.4% 7.1% 11.7% 7.1% -12.3% · · · ·
EBITDA Margin 8-point trend, +263.8% 25.0% 20.3% 21.6% 18.8% 15.0% 19.0% 12.9% -15.2% · · · ·
ROA 12-point trend, +189.4% 13.0% 9.0% 9.3% 6.6% 3.4% 14.8% 4.7% -9.0% -7.7% -18.9% -24.2% -14.6%
ROE 12-point trend, +257.5% 31.4% 28.2% 25.0% 17.2% 7.4% 29.7% 12.3% -20.7% -14.3% -26.0% -31.9% -20.0%
ROIC 12-point trend, +265.6% 25.5% 23.2% 22.0% 16.0% 10.5% 36.0% 15.6% -28.2% -10.5% -22.8% -25.9% -15.4%
Liquidez y Solvencia 3
Datos anuales de Liquidez y Solvencia para DXCM
Métrica Tendencia 202520242023202220212020201920182017201620152014
Current Ratio 12-point trend, -47.6% 1.9 1.5 2.8 2.0 5.1 5.6 5.5 7.6 5.4 2.7 3.5 3.6
Quick Ratio 12-point trend, -43.7% 1.0 0.5 1.0 0.7 2.2 2.0 2.0 6.1 4.8 2.1 2.4 1.8
Interest Coverage 10-point trend, +209.6% · · 29.4 21.0 2.6 3.5 2.4 -8.2 -3.3 -91.3 -142.8 -26.9
Eficiencia 3
Datos anuales de Eficiencia para DXCM
Métrica Tendencia 202520242023202220212020201920182017201620152014
Asset Turnover 8-point trend, -0.6% 0.7 0.6 0.6 0.6 0.5 0.6 0.7 0.7 · · · ·
Inventory Turnover 12-point trend, -52.1% 3.2 2.9 3.1 3.1 2.6 3.6 5.7 6.3 5.0 4.8 4.8 6.6
Receivables Turnover 8-point trend, -26.6% 4.2 4.1 4.3 4.7 5.2 5.4 5.8 5.7 · · · ·
Por Acción 5
Datos anuales de Por Acción para DXCM
Métrica Tendencia 202520242023202220212020201920182017201620152014
Book Value / Share 12-point trend, +293.5% $7.14 $5.38 $5.37 $5.52 $23.21 $19.01 $9.64 $7.37 $4.82 $3.35 $2.71 $1.81
Revenue / Share 7-point trend, -28.1% $11.50 $9.77 $8.51 $6.81 $24.46 $19.76 $15.99 · · · · ·
Cash Flow / Share 7-point trend, +4.3% $3.55 $2.40 $1.76 $1.57 $4.42 $4.88 $3.41 · · · · ·
Cash / Share 12-point trend, +156.8% $2.38 $1.55 $1.47 $1.66 $10.85 $8.51 $4.87 $12.63 $5.07 $1.12 $1.05 $0.93
EPS (TTM) 9-point trend, +460.3% $2.09 $1.42 $1.30 $0.82 $0.53 $1.33 $1.10 $-1.44 $-0.58 · · ·
Tasas de Crecimiento 9
Datos anuales de Tasas de Crecimiento para DXCM
Métrica Tendencia 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, -42.4% 15.6% 11.3% 24.5% 18.8% 27.1% · · · · · · ·
Revenue CAGR 3Y 3-point trend, -27.4% 17.0% 18.1% 23.4% · · · · · · · · ·
Revenue CAGR 5Y 19.3% · · · · · · · · · · ·
EPS YoY 5-point trend, +178.4% 47.2% 9.2% 58.5% 54.7% -60.2% · · · · · · ·
EPS CAGR 3Y 3-point trend, +4915.8% 36.6% 38.9% -0.76% · · · · · · · · ·
EPS CAGR 5Y 9.5% · · · · · · · · · · ·
Net Income YoY 5-point trend, +174.6% 45.1% 6.4% 58.7% 57.3% -60.5% · · · · · · ·
Net Income CAGR 3Y 3-point trend, +7066.0% 34.8% 38.5% -0.50% · · · · · · · · ·
Net Income CAGR 5Y 8.8% · · · · · · · · · · ·
Valoración (TTM) 10
Datos anuales de Valoración (TTM) para DXCM
Métrica Tendencia 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +1698.6% $4.66B $4.03B $3.62B $2.91B $2.45B $1.93B $1.48B $1.03B $718M $573M $402M $259M
Net Income TTM 12-point trend, +3833.5% $836M $576M $542M $341M $217M $550M $101M $-127M $-50M $-66M $-58M $-22M
Market Cap 12-point trend, +2300.7% $25.54B $30.38B $47.82B $43.74B $13.02B $8.88B $5.01B $2.70B $1.25B $1.26B $1.67B $1.06B
P/E 9-point trend, +228.4% 31.8 54.8 95.5 138.1 253.3 69.5 49.7 -20.8 -24.7 · · ·
P/S 12-point trend, +33.5% 5.5 7.5 13.2 15.0 5.3 4.6 3.4 2.6 1.7 2.2 4.2 4.1
P/B 12-point trend, +22.6% 9.3 14.5 23.1 20.5 5.8 4.9 5.7 4.1 3.0 4.4 7.6 7.6
P / Tangible Book 6-point trend, +66.2% 9.6 15.4 25.1 22.6 6.6 5.8 · · · · · ·
P / Cash Flow 12-point trend, -60.7% 17.7 30.7 63.9 65.3 29.4 18.7 15.9 21.9 13.6 22.5 34.1 45.1
P / FCF 12-point trend, -83.5% 23.7 48.2 93.4 143.6 244.3 32.1 37.2 48.0 48.0 2525.3 106.5 143.8
Earnings Yield 9-point trend, +178.0% 3.1% 1.8% 1.1% 0.72% 0.39% 1.4% 2.0% -4.8% -4.0% · · ·

Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años

Estado de resultados
2025-12-312024-12-312023-12-312022-12-312021-12-31
Ingresos $4.66B$4.03B$3.62B$2.91B$2.45B
Margen Bruto % 60.1%60.5%63.2%64.7%68.6%
Margen Operativo % 19.6%14.9%16.5%13.4%10.9%
Beneficio neto $836M$576M$542M$341M$217M
EPS Diluido $2.09$1.42$1.30$0.82$0.53
Balance general
2025-12-312024-12-312023-12-312022-12-312021-12-31
Ratio corriente 1.91.52.82.05.1
Ratio Rápido 1.00.51.00.72.2
Flujo de Efectivo
2025-12-312024-12-312023-12-312022-12-312021-12-31
Flujo de caja libre $1.08B$631M$512M$305M$53M

Últimas noticias Noticias recientes que mencionan a esta empresa

Señales de trading Señales recientes de compra/venta con precio de entrada y ratio riesgo/recompensa

Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos

📊

Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.

Tu selección se guarda y te sigue en todos los tickers.

Propietarios institucionales (13F) 1 087 declarantes · $16.0B total · A fecha de 30 de junio de 2026

Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.

Actividad institucional — Q2 2026 vs trimestre anterior
Nuevas posiciones Posiciones cerradas Aumentado Disminuido Cambio neto de acciones
131 (-28 vs trimestre anterior) 96 (+4 vs trimestre anterior) 386 (+17 vs trimestre anterior) 352 (+6 vs trimestre anterior) +42.0M

Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.

Institución Valor Acciones % de 13F rastreadas Tipo
VANGUARD CAPITAL MANAGEMENT LLC $1 697 876 797 25 209 752 10,61% Acciones
VANGUARD PORTFOLIO MANAGEMENT LLC $1 323 867 969 19 656 540 8,27% Acciones
STATE STREET CORP $1 237 947 284 18 380 806 7,73% Acciones
GEODE CAPITAL MANAGEMENT, LLC $751 533 926 11 199 611 4,70% Acciones
ALLIANCEBERNSTEIN L.P. $734 346 085 11 693 409 4,59% Acciones
WELLINGTON MANAGEMENT GROUP LLP $545 031 559 8 092 525 3,41% Acciones
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $462 914 937 6 873 273 2,89% Acciones
NORGES BANK $462 565 862 6 868 090 2,89% Acciones
Castle Hook Partners LP $260 667 534 3 870 342 1,63% Acciones
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $231 614 091 3 438 962 1,45% Acciones
AMERICAN CENTURY COMPANIES INC $206 860 340 3 071 423 1,29% Acciones
JANUS HENDERSON GROUP PLC $162 720 013 2 591 083 1,02% Acciones
BNP PARIBAS FINANCIAL MARKETS $152 790 681 2 268 607 0,95% Acciones
VANGUARD FIDUCIARY TRUST CO $149 327 006 2 217 179 0,93% Acciones
Employees Provident Fund Board $147 498 453 2 190 029 0,92% Acciones
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $129 989 908 2 069 903 0,81% Acciones
DIMENSIONAL FUND ADVISORS LP $114 711 656 1 703 218 0,72% Acciones
BLAIR WILLIAM & CO/IL $112 182 565 1 665 665 0,70% Acciones
RENAISSANCE TECHNOLOGIES LLC $109 834 111 1 630 796 0,69% Acciones
RAYMOND JAMES FINANCIAL INC $102 869 971 1 527 394 0,64% Acciones
BANK OF AMERICA CORP /DE/ $97 103 277 1 441 771 0,61% Acciones
AMERIPRISE FINANCIAL INC $93 336 259 1 385 802 0,58% Acciones
VICTORY CAPITAL MANAGEMENT INC $92 130 221 1 367 932 0,58% Acciones
DSM CAPITAL PARTNERS LLC $91 537 742 1 359 135 0,57% Acciones
Mitsubishi UFJ Asset Management Co., Ltd. $89 939 931 1 335 411 0,56% Acciones
ROYAL BANK OF CANADA $88 321 000 1 311 368 0,55% Acciones
GOLDMAN SACHS GROUP INC $87 360 493 1 297 112 0,55% Acciones
CI INVESTMENTS INC. $86 724 103 1 287 663 0,54% Acciones
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $85 826 193 1 274 331 0,54% Acciones
BANK OF NOVA SCOTIA $85 283 937 1 266 285 0,53% Acciones
DNB Asset Management AS $84 543 377 1 255 284 0,53% Acciones
Nearwater Capital Markets, Ltd $84 187 500 1 250 000 0,53% Acciones
Stephens Investment Management Group LLC $81 126 645 1 204 553 0,51% Acciones
Swedbank AB $78 528 215 1 165 972 0,49% Acciones
BlackRock, Inc. $77 389 460 1 149 064 0,48% Acciones
FMR LLC $77 274 023 1 147 350 0,48% Acciones
CITADEL ADVISORS LLC $75 864 589 1 126 423 0,47% Acciones
FIRST TRUST ADVISORS LP $74 838 523 1 111 188 0,47% Acciones
HSBC HOLDINGS PLC $73 861 872 1 080 800 0,46% Opción de compra
Swiss National Bank $73 108 425 1 085 500 0,46% Acciones
CANADA PENSION PLAN INVESTMENT BOARD $71 040 241 1 054 792 0,44% Acciones
ADAGE CAPITAL PARTNERS GP, L.L.C. $67 343 265 999 900 0,42% Acciones
CITADEL ADVISORS LLC $64 656 000 960 000 0,40% Opción de venta
Legal & General Group Plc $64 638 083 959 734 0,40% Acciones
Sumitomo Mitsui Trust Group, Inc. $64 478 600 957 366 0,40% Acciones
BAILLIE GIFFORD & CO $63 928 755 949 202 0,40% Acciones
CIBC Bancorp USA Inc. $62 958 645 932 286 0,39% Acciones
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND $61 865 555 918 568 0,39% Acciones
PRINCIPAL FINANCIAL GROUP INC $59 044 465 876 681 0,37% Acciones
Chicago Capital, LLC $58 393 062 867 009 0,36% Acciones
Fisher Funds Management LTD $56 637 983 840 950 0,35% Acciones
Vanguard Global Advisers, LLC $56 107 871 833 079 0,35% Acciones
JANE STREET GROUP, LLC $56 062 140 832 400 0,35% Opción de compra
Bellevue Group AG $55 394 634 822 489 0,35% Acciones
Tri Locum Partners LP $55 259 261 820 479 0,35% Acciones
RHUMBLINE ADVISERS $51 735 803 768 165 0,32% Acciones
ENVESTNET ASSET MANAGEMENT INC $51 168 667 759 743 0,32% Acciones
UBS Group AG $51 066 858 758 231 0,32% Acciones
Allianz Asset Management GmbH $50 820 963 809 251 0,32% Acciones
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. $50 518 000 750 088 0,32% Acciones
BARCLAYS PLC $50 351 331 747 607 0,31% Acciones
VANGUARD ASSET MANAGEMENT, Ltd $49 968 851 741 928 0,31% Acciones
TWO SIGMA ADVISERS, LP $49 649 804 748 076 0,31% Acciones
Smith Group Asset Management, LLC $47 235 720 701 347 0,30% Acciones
NATIONAL BANK OF CANADA /FI/ $46 761 576 694 307 0,29% Acciones
Assenagon Asset Management S.A. $46 716 317 693 635 0,29% Acciones
NEUBERGER BERMAN GROUP LLC $46 117 886 684 750 0,29% Acciones
CAPITOLIS LIQUID GLOBAL MARKETS LLC $44 760 810 664 600 0,28% Acciones
PEREGRINE CAPITAL MANAGEMENT LLC $44 759 530 664 581 0,28% Acciones
Capital International Investors $44 585 633 661 999 0,28% Acciones
CAPITAL FUND MANAGEMENT S.A. $44 543 875 661 379 0,28% Acciones
Pictet Asset Management Holding SA $44 534 379 661 238 0,28% Acciones
National Pension Service $44 471 811 660 309 0,28% Acciones
California Public Employees Retirement System $42 988 899 638 291 0,27% Acciones
Korea Investment CORP $42 608 237 632 639 0,27% Acciones
ING GROEP NV $41 334 513 613 727 0,26% Acciones
Susquehanna Portfolio Strategies, LLC $41 226 753 612 127 0,26% Acciones
MIG Capital, LLC $40 190 154 605 547 0,25% Acciones
Universal- Beteiligungs- und Servicegesellschaft mbH $39 472 718 584 004 0,25% Acciones
Quantinno Capital Management LP $39 303 248 583 567 0,25% Acciones
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $36 898 831 587 561 0,23% Acciones
FRONTIER CAPITAL MANAGEMENT CO LLC $36 855 267 547 220 0,23% Acciones
FACTORY MUTUAL INSURANCE CO $36 222 851 537 830 0,23% Acciones
Woodline Partners LP $36 146 880 536 702 0,23% Acciones
Parkman Healthcare Partners LLC $36 016 557 534 767 0,23% Acciones
MARSHALL WACE, LLP $35 884 349 532 804 0,22% Acciones
Walleye Trading LLC $35 823 465 531 900 0,22% Opción de compra
EVENTIDE ASSET MANAGEMENT, LLC $33 574 377 498 202 0,21% Acciones
Blue Sparrow, LLC /DE $32 368 410 480 600 0,20% Acciones
Trexquant Investment LP $31 938 380 474 215 0,20% Acciones
Cubist Systematic Strategies, LLC $31 905 647 474 151 0,20% Acciones
UBS Group AG $31 896 960 473 600 0,20% Opción de venta
Mitsubishi UFJ Trust & Banking Corp $31 227 164 463 655 0,20% Acciones
USS Investment Management Ltd $30 910 132 459 050 0,19% Acciones
OFI INVEST ASSET MANAGEMENT $29 454 211 500 000 0,18% Acciones
TEACHER RETIREMENT SYSTEM OF TEXAS $29 397 534 436 489 0,18% Acciones
ProShare Advisors LLC $28 566 636 424 152 0,18% Acciones
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $28 528 135 427 840 0,18% Acciones
SIRIOS CAPITAL MANAGEMENT L P $28 315 152 420 418 0,18% Acciones
Bridgewater Associates, LP $27 002 568 400 929 0,17% Acciones

Informantes de la empresa 60 insiders · 36 directivos · 23 consejeros

Insider Rol Última actividad Acciones en propiedad Compras 12m Ventas 12m Neto 12m
Jacob Steven Leach President, CEO, and Director 22 de mayo de 2026 F 420 359 2 0 $1 001 761
Andrew P Rasdal President & CEO 2 de mayo de 2006 M 2 944 0 0 $0
Jess Roper SVP, CFO 22 de marzo de 2017 S 8 452 0 0 $0
Steven J Kemper Chief Financial Officer 15 de mayo de 2007 A 26 255 0 0 $0
Quentin S. Blackford Chief Operating Officer 10 de septiembre de 2021 S 19 280 0 0 $0
Kevin R Sayer Executive Chair 20 de julio de 2026 S 328 970 0 3 $-5 895 098
Jon Coleman EVP, Chief Commercial Officer 4 de junio de 2026 S 95 450 0 2 $-722 628
Sadie Stern EVP Chief People & Culture Off 22 de mayo de 2026 F 130 059 0 1 $-117 280
Jereme M Sylvain EVP, Chief Financal Officer 22 de mayo de 2026 F 151 841 0 1 $-357 796
Matthew Vincent Dolan EVP, Strategy & Corporate Dev 29 de enero de 2025 S 42 044 0 0 $0
Teri L Lawver EVP Chief Commercial Officer 12 de marzo de 2024 S 66 641 0 0 $0
Paul R Flynn EVP Global Revenue 18 de diciembre de 2023 D 48 949 0 0 $0
Barry J. Regan EVP Operations 18 de diciembre de 2023 D 58 469 0 0 $0
Steven Robert Pacelli EVP Managing Director Dexcom V 24 de noviembre de 2023 S 124 775 0 0 $0
Girish Naganathan EVP Chief Technology Officer 9 de noviembre de 2023 S 47 725 0 0 $0
Shelly Ramasamy Selvaraj SVP Chief Information Officer 11 de septiembre de 2023 D 48 453 0 0 $0
Donald Abbey EVP Global Business Services I 10 de marzo de 2023 D 208 023 0 0 $0
Andrew K Balo EVP Regulatory Strategy Clinic 10 de marzo de 2023 D 50 908 0 0 $0
Chad Patterson EVP Global Marketing 9 de mayo de 2022 S 13 675 0 0 $0
Sumi Shrishrimal SVP Chief Risk Officer 9 de marzo de 2022 D 13 789 0 0 $0
Patrick Michael Murphy EVP, Chief Legal Officer 9 de septiembre de 2021 S 16 254 0 0 $0
Richard Doubleday EVP Chief Commercial Officer 23 de marzo de 2021 S 6 654 0 0 $0
Jeffrey Moy EVP Operations 9 de septiembre de 2020 D 34 784 0 0 $0
Heather S Ace SVP Human Resources 11 de marzo de 2020 S 38 584 0 0 $0
Terrance H Gregg Executive Chairman 16 de julio de 2018 S 50 882 0 0 $0
John Lister General Manager, EMEA 9 de marzo de 2017 M 84 034 0 0 $0
Peter Gerhardsson VP, Int'l Bus. Dev. 16 de noviembre de 2010 P 3 387 0 0 $0
David Carner VP, Quality Assurance 16 de agosto de 2010 A 0 0 $0
Laura Johnson V.P., Intellectual Property 12 de marzo de 2010 A 0 0 $0
Richard Yang V.P., Strategic Affairs 12 de marzo de 2010 A 0 0 $0
Claudia Graham VP Marketing 12 de marzo de 2010 A 18 741 0 0 $0
Rodney L Kellogg Vice President of Sales 19 de mayo de 2008 A 0 0 $0
James H Brauker VP Research & Development 24 de marzo de 2008 A 53 125 0 0 $0
Mark Brister VP, Advanced Development Team 2 de noviembre de 2007 A 10 967 0 0 $0
John Riolo VP of Quality Assurance 2 de agosto de 2007 A 0 0 $0
Tae Andrews Vice President of Marketing 9 de marzo de 2007 A 0 0 $0
Mark G Foletta Consejero 3 de agosto de 2026 S 48 852 0 4 $-627 183
Albert Frederick Osterloh IV Consejero 28 de mayo de 2026 A 8 691 0 0 $0
Euan A. Ashley Consejero 28 de mayo de 2026 A 12 731 0 0 $0
Rimma Driscoll Consejero 28 de mayo de 2026 A 17 319 0 0 $0
Kyle Malady Consejero 28 de mayo de 2026 A 28 242 0 1 $-53 934
Richard Alexander Collins Consejero 28 de mayo de 2026 A 5 605 0 2 $-389 410
Renee D Gala Consejero 28 de mayo de 2026 A 12 486 0 0 $0
Steven R Altman Consejero 28 de mayo de 2026 A 5 565 0 0 $0
Karen M Dahut Consejero 8 de mayo de 2025 G 17 779 0 0 $0
Eric Topol Consejero 8 de mayo de 2025 G 380 545 0 0 $0
Barbara Kahn Consejero 18 de mayo de 2024 G 22 575 0 0 $0
Jay S Skyler Consejero 18 de mayo de 2023 G 63 348 0 0 $0
Jonathan T Lord MD Consejero 1 de septiembre de 2016 S 52 820 0 0 $0
Martin Doordan Consejero 1 de junio de 2012 A 39 633 0 0 $0

Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto

Propiedad de ETFs Mantenido por 197 ETFs

El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.

Fondo Ponderación Unidades A fecha de Fuente
TMFM · RBB Fund, Inc. 5,18% 81 981 NS 31 de mayo de 2026 N-PORT
HEAL · Global X Funds 4,89% 16 599 NS 31 de mayo de 2026 N-PORT
SNSR · Global X Funds 4,74% 161 491 NS 31 de mayo de 2026 N-PORT
IHI · iShares Trust 4,54% 1 828 483 SH 8 de agosto de 2026 Diario
GDOC · Goldman Sachs ETF Trust 2,79% 7 621 NS 31 de mayo de 2026 N-PORT
TMFG · RBB Fund, Inc. 2,33% 112 503 NS 31 de mayo de 2026 N-PORT
AGNG · Global X Funds 2,01% 22 316 NS 31 de mayo de 2026 N-PORT
HRTS · Tema ETF Trust 1,92% 13 512 NS 31 de mayo de 2026 N-PORT
JMID · Janus Detroit Street Trust 1,91% 5 848 NS 30 de abril de 2026 N-PORT
FGSI · First Trust Exchange-Traded Fund IV 1,89% 952 NS 30 de abril de 2026 N-PORT
RSPH · Invesco Exchange-Traded Fund Trust 1,72% 158 549 SH 8 de agosto de 2026 Diario
SPGP · Invesco Exchange-Traded Fund Trust 1,42% 389 654 SH 8 de agosto de 2026 Diario
TMFX · RBB Fund, Inc. 1,37% 5 955 NS 31 de mayo de 2026 N-PORT
FMED · Fidelity Covington Trust 1,18% 6 533 NS 31 de mayo de 2026 N-PORT
MID · AMERICAN CENTURY ETF TRUST 1,17% 15 853 NS 31 de mayo de 2026 N-PORT
DTEC · ALPS ETF Trust 1,01% 10 206 NS 31 de mayo de 2026 N-PORT
QGRO · AMERICAN CENTURY ETF TRUST 1,01% 302 231 NS 31 de mayo de 2026 N-PORT
LGRO · ALPS ETF Trust 1,00% 18 376 NS 31 de mayo de 2026 N-PORT
QQQG · Pacer Funds Trust 0,99% 1 867 NS 30 de abril de 2026 N-PORT
AGRW · ALLSPRING EXCHANGE-TRADED FUNDS TRU… 0,97% 17 329 NS 30 de abril de 2026 N-PORT
RILA · Spinnaker ETF Series 0,92% 6 459 NS 30 de abril de 2026 N-PORT
MMID · MFS Active Exchange Traded Funds Tr… 0,91% 4 208 NS 31 de mayo de 2026 N-PORT
IWP · iShares Trust 0,91% 2 217 346 SH 8 de agosto de 2026 Diario
SDG · iShares Trust 0,87% 18 232 SH 8 de agosto de 2026 Diario
MEDI · Harbor ETF Trust 0,84% 3 888 NS 30 de abril de 2026 N-PORT
QQQE · Direxion Shares ETF Trust 0,80% 163 528 NS 30 de abril de 2026 N-PORT
FWD · AB Active ETFs, Inc. 0,76% 296 418 NS 31 de mayo de 2026 N-PORT
AVMV · AMERICAN CENTURY ETF TRUST 0,67% 56 679 NS 31 de mayo de 2026 N-PORT
JDOC · J.P. Morgan Exchange-Traded Fund Tr… 0,64% 1 196 NS 30 de abril de 2026 N-PORT
QNXT · iShares Trust 0,59% 2 014 SH 8 de agosto de 2026 Diario
VOT · VANGUARD INDEX FUNDS 0,57% 2 956 203 SH 8 de agosto de 2026 Diario
IYH · iShares Trust 0,52% 229 458 SH 8 de agosto de 2026 Diario
SPHQ · Invesco Exchange-Traded Fund Trust 0,46% 1 074 035 SH 8 de agosto de 2026 Diario
IMCG · iShares Trust 0,43% 209 424 SH 8 de agosto de 2026 Diario
RXL · ProShares Trust 0,41% 4 013 NS 31 de mayo de 2026 N-PORT
QIDX · Spinnaker ETF Series 0,41% 2 617 NS 30 de abril de 2026 N-PORT
IXJ · iShares Trust 0,40% 202 443 SH 8 de agosto de 2026 Diario
FXH · First Trust Exchange-Traded AlphaDE… 0,38% 56 496 NS 30 de abril de 2026 N-PORT
VHT · VANGUARD WORLD FUND 0,38% 1 156 710 SH 8 de agosto de 2026 Diario
FHLC · FIDELITY COVINGTON TRUST 0,38% 179 798 NS 30 de abril de 2026 N-PORT
VFQY · VANGUARD WELLINGTON FUND 0,34% 23 742 SH 8 de agosto de 2026 Diario
MMLG · First Trust Exchange-Traded Fund VI… 0,33% 4 233 NS 31 de mayo de 2026 N-PORT
AVMC · AMERICAN CENTURY ETF TRUST 0,33% 18 233 NS 31 de mayo de 2026 N-PORT
CURE · Direxion Shares ETF Trust 0,33% 7 675 NS 30 de abril de 2026 N-PORT
AVUQ · AMERICAN CENTURY ETF TRUST 0,32% 11 239 NS 31 de mayo de 2026 N-PORT
GINN · Goldman Sachs ETF Trust 0,32% 9 251 NS 31 de mayo de 2026 N-PORT
AVLV · AMERICAN CENTURY ETF TRUST 0,32% 558 304 NS 31 de mayo de 2026 N-PORT
TMFE · RBB Fund, Inc. 0,32% 3 671 NS 31 de mayo de 2026 N-PORT
FTC · First Trust Exchange-Traded AlphaDE… 0,30% 64 292 NS 30 de abril de 2026 N-PORT
BFOR · ALPS ETF Trust 0,26% 7 662 NS 31 de mayo de 2026 N-PORT